Recent Updates — MDLN
On October 14, 2026, Medline Inc. initiated a voluntary field action involving the removal and discontinuation of all Medline Brand beds, including homecare, bariatric, and long-term care models, along with associated accessories and parts. The company estimates costs up to $220 million for inventory impairment, disposal, and customer credits, expected in 2026 and 2027. Affected products generated approximately $60 million in net sales over the trailing twelve months ended June 27, 2026. Medline does not expect a material impact on fiscal year 2026 results or full-year guidance. The company operates in the healthcare supply and medical equipment industry.
Joseph P. Baratta notified the Board of Directors of Medline Inc. of his decision to resign from the Board, effective as of December 31, 2026. The resignation coincides with Mr. Baratta's previously announced departure from Blackstone Inc. and is not the result of any disagreement with the Company related to its operations, policies, or practices. Medline Inc. operates in the healthcare industry, providing medical supplies and equipment.
Medline Inc. reported second quarter and first six months 2026 results on August 5, 2026. Second quarter net sales increased 11.6% to $7.7 billion, while net income decreased 58.3% to $139 million due to a $336 million loss from a fire at its Tracy, California distribution center and higher operating expenses. Adjusted EBITDA rose 13.4% to $1.1 billion, supported by $243 million in net IEEPA tariff refund benefits partially offset by $89 million in customer repayments. The company updated its full year 2026 organic sales growth guidance to 9.0%-10.0% and Adjusted EBITDA guidance to $3.3-$3.4 billion, citing inflationary pressures and retail channel softness. Medline Inc. is the largest provider of medical-surgical products and supply chain solutions serving all points of care.
Stephen L. Miller, Chief Operating Officer of Medline Inc., notified the company of his intention to retire for health-related reasons, effective August 30, 2026. The company has initiated a search for a successor. Medline Inc. is a medical products and services company.
Medline Inc. issued $1,250.0 million in 5.000% senior secured notes due 2031 and $750.0 million in 5.250% senior secured notes due 2033, while refinancing its existing term loan with a new $2,750.0 million facility. Additionally, selling stockholders completed an underwritten public offering of 72,554,594 shares of Class A common stock at $37.00 per share.